Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
E.D. Tex.

Warner Chilcott (US), LLC et al v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01471 (E.D. Tex. Aug. 10, 2017)

Adopted Report and recommendation (or magistrate's order) adopted
Court
U.S. District Court for the Eastern District of Texas, Marshall Division
Case No.
No. 2:15-cv-01471, Dkt. No. 220
Decided
August 10, 2017
Judge
See opinion
Document
Order
Docket Entry
ORDER ADOPTING REPORT AND RECOMMENDATION for 197 Report and Recommendation, OVERRULING 218 Plaintiff's Objections; and DENYING 146 SEALED MOTION to Dismiss Action Against Teva Pharmaceuticals USA, Inc. for Lack of Subject-Matter Jurisdictio…
Length
1 page

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF TEXAS

MARSHALL DIVISION

ALLERGAN SALES, LLC, AND §

QUALICAPS CO., LTD., §

§ Case No. 2:15-CV-01471-JRG-RSP (Lead) Plaintiffs, § § v. § § TEVA PHARMACEUTICALS USA, INC., §

§ Defendant. §

ORDER

Plaintiffs object to Magistrate Judge Payne’s recommendation that Plaintiffs’ motion to dismiss Teva Pharmaceuticals USA, Inc. (“Teva”) for lack of subject matter jurisdiction be denied. Dkt. 218. Having reviewed Plaintiffs’ objections, and having considered Judge Payne’s Report and Recommendation de novo, the Court finds no reason to reject or modify the recommended disposition. See Fed. R. Civ. P. 72(b)(3); 28 U.S.C. § 636(b)(1)(C).

Accordingly, it is ORDERED: (1) Plaintiffs’ objections, Dkt. 218, are OVERRULED. (2) Magistrate Judge Payne’s Report and Recommendation, Dkt. 197, is ADOPTED. (3) Plaintiffs’ motion to dismiss Teva for lack of subject matter jurisdiction, Dkt. 146, is DENIED.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Warner Chilcott (US), LLC et al v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01471 (E.D. Tex. Aug. 10, 2017).

govinfo ID
USCOURTS-txed-2_15-cv-01471-2
Permalink
https://patentcasewatch.com/opinions/USCOURTS-txed-2_15-cv-01471-2

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.